Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...
Amazon Has AMD Radeon RX 9070 and 9070 XT Prebuilt Gaming PCs for as Low as $1350
We rated the AMD Radeon RX 9070 an 8/10. It costs the same as the new Nvidia GeForce RTX 5070 but it performs better in the ...
This Highly Rated 75-Inch 4K ULED TV Is Under $500 Right Now
The Hisense 75U6H ULED TV is now $488 (down from $698), offering a budget-friendly 75-inch 4K experience. It features quantum ...
Leaked images of an AMD GPU have me wishing it was real
The RX 9070 XT GPU, if it’s real, was likely given out to AMD’s brand partners prior to the launch of the RX 9070 XT/non-XT. Whoever got their hands on this card ended up keeping it and selling it, ...
Kodiak Sciences Completes Enrollment In Second Registrational Trial Of Tarcocimab In Patients With Diabetic Retinopathy
Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. <li /> GLOW2 study design mirrors GLOW1 study, ...
My Favorite Budget-Friendly QLED TV Is $320 Off Right Now
LED tech to improve picture quality with more realistic colors, better contrast, and higher brightness. After testing this TV ...
4D Molecular Therapeutics, Inc.: 4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.